RetinaFusion: A Comprehensive Ensemble for Diabetic Eye Care

Given the increasing worldwide occurrence of diabetes, which is expected to affect 9.9% of the world’s inhabitants by 2045, the need for efficient chronic eye treatments has become even more urgent. This unique ensemble technique tackles the complex issues posed by diabetic retinopathy (DR). By utilizing state-of-the-art equipment instruction and models using deep learning, it showcases exceptional precision in identifying indications of diabetic retinopathy (DR), such as microaneurysms, hemorrhages, and retinal edema. The system’s incorporation of clinical data enhances its ability to make predictions, making it easier to implement early intervention techniques. By doing thorough validation, this tool emerges as a powerful solution that has the potential to greatly reduce the burden of retinopathy from diabetes on world health. By actively participating in the proactive handling of diabetic retinopathy (DR) and providing a source of optimism for persons who are at danger of permanent vision loss, we are leading the way in enhancing diabetic eye care. We will use plasma reports and digital retinal images to reliably assess the severity of these conditions. To accomplish this, we initially ascertain the presence or absence of diabetes in the patient. The utilization of the K Nearest Neighbors machine learning classification technique has facilitated this achievement. This offers a more positive future for those affected by this widespread consequence of diabetes.